Top

Gepubliceerd in:

02-10-2020 | Original Article

Psychotherapy, Atomoxetine or Both? Preliminary Evidence from a Comparative Study of Three Types of Treatment for Attention-Deficit/Hyperactivity Disorder in Children

Auteurs: Daniel David, Anca Dobrean, Costina Ruxandra Păsărelu, Felicia Iftene, Viorel Lupu, Elena Predescu, Manfred Döpfner

Gepubliceerd in: Cognitive Therapy and Research | Uitgave 1/2021

Abstract

Background

The current study aimed to investigate using a superiority framework the efficacy of a combined treatment (cognitive-behavioral therapy based on behavioral components derived from classical behavioral therapy modifications and cognitive components mainly derived from rational emotive behavior therapy, plus an attention training component in a virtual environment (CBT/REBT + ATX, N = 20) as compared to psychotherapy alone (CBT/REBT, delivered over 16 weeks, N = 18—reference treatment) and non-stimulant medication alone (atomoxetine; ATX, N = 21—reference treatment) for children with Attention-Deficit/Hyperactivity Disorder (ADHD).

Methods

A three-arm pilot randomized controlled trial was conducted. Fifty-nine children (M_age = 8.46, SD = 1.57) were randomly allocated to one of the 3 conditions.

Results

Our preliminary findings indicated a significant difference between the CBT/REBT + ATX and ATX group at post-treatment for the total ADHD symptoms rated by parent, d = 1.30, 95% CI [0.63, 1.98], p = 0.010.

Conclusions

The combined treatment seems to be superior to the medication alone on parent ratings on ADHD symptoms, however, on clinical ratings on ADHD diagnosis and functioning there are no significant group differences between treatments. Future larger trials with follow-up assessments are needed to test the stability of the effects over time.

vorige artikel Does Self-Efficacy Predict Functioning in Older Adults with Schizophrenia? A Cross-Sectional and Longitudinal Mediation Analysis

volgende artikel Developmental Differences in Child and Adolescent Reasoning About Anxiety Sensations

Alleen toegankelijk voor geautoriseerde gebruikers

Achenbach, T. M., & Rescorla, L. A. (2001). Manual for the ASEBA school-age forms and profiles. Burlington: University of Vermont, Research Center for Children, Youth, & Families.

American Psychiatric Association. (2000). Diagnostic and statistical manual of mental Disorders (4th ed., Revise ed.). Washington, DC: American Psychiatric Association.

American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Arlington, VA: American Psychiatric Publishing.

Anastopoulos, A. D., O'Rourke, S. R., & Bray, A. C. (2018). Facilitating understanding and management of attention-deficit/hyperactivity disorder. In P. C. Kendall (Ed.), Cognitive therapy with children and adolescents: A casebook for clinical practice (pp. 195–220). New York: Guilford Press.

Anton, R., Opris, D., Dobrean, A., & David, D. (2009). Virtual reality in the rehabilitation of Attention Deficit/Hyperactivity Disorder. Instrument construction principles. Journal of Evidence-Based Psychotherapies, 9(2), 235.

Beau-Lejdstrom, R., Douglas, I., Evans, S. J. W., & Smeeth, L. (2016). Latest trends in ADHD drug prescribing patterns in children in the UK: Prevalence, incidence and persistence. British Medical Journal Open, 6(6), e010508. https://doi.org/10.1136/bmjopen-2015-010508.CrossRef

Bioulac, S., Micoulaud-Franchi, J.-A., Maire, J., Bouvard, M. P., Rizzo, A. A., Sagaspe, P., et al. (2020). Virtual remediation versus methylphenidate to improve distractibility in children with ADHD: A Controlled Randomized Clinical Trial Study. Journal of Attention Disorders, 24(2), 326–335. https://doi.org/10.1177/1087054718759751.CrossRefPubMed

Boyer, B. E., Doove, L. L., Geurts, H. M., Prins, P. J. M., Van Mechelen, I., & Van der Oord, S. (2016). Qualitative treatment-subgroup interactions in a randomized clinical trial of treatments for adolescents with ADHD: Exploring what cognitive-behavioral treatment works for whom. PLoS ONE, 11(3), e0150698. https://doi.org/10.1371/journal.pone.0150698.CrossRefPubMedPubMedCentral

Carl, E., Stein, A. T., Levihn-Coon, A., Pogue, J. R., Rothbaum, B., Emmelkamp, P., … Powers, M. B. (2019). Virtual reality exposure therapy for anxiety and related disorders: A meta-analysis of randomized controlled trials. Journal of Anxiety Disorders, 61, 27–36. https://doi.org/10.1016/j.janxdis.2018.08.003.

Catalá-López, F., Hutton, B., Núñez-Beltrán, A., Page, M. J., Ridao, M., Macías Saint-Gerons, D., … Moher, D. (2017). The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: A systematic review with network meta-analyses of randomised trials. PLoS ONE, 12(7), e0180355. https://doi.org/10.1371/journal.pone.0180355.

Chacko, A., Wymbs, B. T., Rajwan, E., Wymbs, F., & Feirsen, N. (2017). Characteristics of parents of children with ADHD who never attend, drop out, and complete behavioral parent training. Journal of Child and Family Studies, 26(3), 950–960. https://doi.org/10.1007/s10826-016-0618-z.CrossRef

Cheung, K., Verhamme, K. M. C., Herings, R., Visser, L. E., & Stricker, B. H. (2019). Methylphenidate treatment initiated during childhood is continued in adulthood in half of the study population. Journal of Child and Adolescent Psychopharmacology, 29(6), 426–432. https://doi.org/10.1089/cap.2018.0170.

Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). Hillsdale: Erlbaum Associates.

Comeau, J., Georgiades, K., Duncan, L., Wang, L., Boyle, M. H., & 2014 Ontario Child Health Study Team. (2019). Changes in the prevalence of child and youth mental disorders and perceived need for professional help between 1983 and 2014: Evidence from the Ontario Child Health Study. The Canadian Journal of Psychiatry. https://doi.org/10.1177/0706743719830035.

Cortese, S., Adamo, N., Del Giovane, C., Mohr-Jensen, C., Hayes, A. J., Carucci, S., … Cipriani, A. (2018). Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: A systematic review and network meta-analysis. The Lancet Psychiatry, 5, 727–738. https://doi.org/10.1016/S2215-0366(18)30269-4.

David, D., Lynn, S. J., & Ellis, A. (2010). Rational and irrational beliefs: Research, theory, and clinical practice. Oxford: Oxford University Press.

David, O. A., & DiGiuseppe, R. (2016). The rational positive parenting program. In O. A. David & R. DiGiuseppe (Eds.), The rational positive parenting program (pp. 15–48). Cham: Springer. https://doi.org/10.1007/978-3-319-22339-1_3.

Dobrean, A., Păsărelu, C.-R., Balazsi, R., & Predescu, E. (2019). Measurement invariance of the ADHD Rating Scale–IV home and school versions across age, gender, clinical status, and informant. Assessment. https://doi.org/10.1177/1073191119858421.CrossRefPubMed

Dobrean, A., Rusu, C., Comsa, M., & Balazsi, R. (2005). Standardizarea pe populatia Romaniei a testului Matrici Progresive Raven Color Forma Paralel. In J. Raven, J. C. Raven, & J. H. Court (Eds.), Manual Raven: Sectiunea 2, Matrici Progresive Color. Cluj-Napoca: Editura ASCR.

Döpfner, M., Breuer, D., Schürmann, S., Metternich, T. W., Rademacher, C., & Lehmkuhl, G. (2004a). Effectiveness of an adaptive multimodal treatment in children with Attention-Deficit Hyperactivity Disorder – global outcome. European Child & Adolescent Psychiatry, 13(Suppl 1), I117–129. https://doi.org/10.1007/s00787-004-1011-9.CrossRef

Döpfner, M., Ise, E., Breuer, D., Rademacher, C., Metternich-Kaizman, T. W., & Schürmann, S. (2016). Long-term course after adaptive multimodal treatment for children with ADHD: An 8-year follow-up. Journal of Attention Disorders, 24(1), 145–162. https://doi.org/10.1177/1087054716659138.CrossRefPubMed

Döpfner, M., Ise, E., Metternich-Kaizman, T. W., Schürmann, S., Rademacher, C., & Breuer, D. (2015). Adaptive multimodal treatment for children with attention-deficit-/hyperactivity disorder: An 18 month follow-up. Child Psychiatry & Human Development, 46(1), 44–56. https://doi.org/10.1007/s10578-014-0452-8.

Döpfner, M., Schürmann, S., & Lehmkuhl, G. (2004b). Copilul hiperactiv si incapatanat. Cluj-Napoca: Romanian Psychological Testing Services.

Doshi, J. A., Hodgkins, P., Kahle, J., Sikirica, V., Cangelosi, M. J., Setyawan, J., … Neumann, P. J. (2012). Economic impact of childhood and adult attention-deficit/hyperactivity disorder in the United States. Journal of the American Academy of Child & Adolescent Psychiatry, 51(10), 990–1002.e2. https://doi.org/10.1016/j.jaac.2012.07.008.

Doyle, K. A., & Terjesen, M. D. (2006). Rational-emotive behavior therapy and attention deficit hyperactivity disorder. In A. Ellis & M. E. Bernard (Eds.), Rational emotive behavioral approaches to childhood disorders (pp. 281–309). Cham: Springer. https://doi.org/10.1007/0-387-26375-6_10.

DuPaul, G. J., Power, T. J., Anastopoulos, A. D., & Reid, R. (1998). ADHD rating scale-IV: Checklists, norms and clinical interpretation. New York: Guilford Publications.

Ellis, A. (1994). Reason and emotion in psychotherapy (revised and updated ed.). New York: Birch Lane Press.

Evans, S. W., Owens, J. S., Wymbs, B. T., & Ray, A. R. (2018). Evidence-based psychosocial treatments for children and adolescents with attention deficit/hyperactivity disorder. Journal of Clinical Child and Adolescent Psychology: The Official Journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53, 47(2), 157–198. https://doi.org/10.1080/15374416.2017.1390757.CrossRef

Faul, F., Erdfelder, E., Lang, A.-G., & Buchner, A. (2007). G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behavior Research Methods, 39(2), 175–191.CrossRef

Ferguson, C. J. (2009). An effect size primer: A guide for clinicians and researchers. Professional Psychology: Research and Practice, 40(5), 532.CrossRef

Gellatly, R., & Beck, A. T. (2016). Catastrophic thinking: A transdiagnostic process across psychiatric disorders. Cognitive Therapy and Research, 40(4), 441–452. https://doi.org/10.1007/s10608-016-9763-3.

Gonzalez, J. E., Nelson, J. R., Gutkin, T. B., Saunders, A., Galloway, A., & Shwery, C. S. (2004). Rational emotive therapy with children and adolescents: A meta-analysis. Journal of Emotional and Behavioral Disorders, 12(4), 222–235. https://doi.org/10.1177/10634266040120040301.CrossRef

Handen, B. L., Aman, M. G., Arnold, L. E., Hyman, S. L., Tumuluru, R. V., Lecavalier, L., … Smith, T. (2015). Atomoxetine, parent training, and their combination in children with autism spectrum disorder and attention-deficit/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 54(11), 905–915. https://doi.org/10.1016/j.jaac.2015.08.013.

Hanwella, R., Senanayake, M., & de Silva, V. (2011). Comparative efficacy and acceptability of methylphenidate and atomoxetine in treatment of attention deficit hyperactivity disorder in children and adolescents: A meta-analysis. BMC Psychiatry, 11, 176. https://doi.org/10.1186/1471-244X-11-176.CrossRefPubMedPubMedCentral

Hien, D., Matzner, F. J., First, M. B., Spitzer, R. L., Gibbon, M., & Williams, J. B. W. (1994). Structured clinical interview for DSM-IV-child edition (version 1.0). New York: Columbia University.

Holmberg, K., & Bölte, S. (2014). Do symptoms of ADHD at ages 7 and 10 predict academic outcome at age 16 in the general population? Journal of Attention Disorders, 18(8), 635–645. https://doi.org/10.1177/1087054712452136.CrossRefPubMed

Hutchison, S. L., Ghuman, J. K., Ghuman, H. S., Karpov, I., & Schuster, J. M. (2016). Efficacy of atomoxetine in the treatment of attention-deficit hyperactivity disorder in patients with common comorbidities in children, adolescents and adults: A review. Therapeutic Advances in Psychopharmacology. https://doi.org/10.1177/2045125316647686.CrossRefPubMedPubMedCentral

Jensen, P. S., Arnold, L. E., Swanson, J. M., Vitiello, B., Abikoff, H. B., Greenhill, L. L., … Hur, K. (2007). 3-year follow-up of the NIMH MTA study. Journal of the American Academy of Child and Adolescent Psychiatry, 46(8), 989–1002. https://doi.org/10.1097/CHI.0b013e3180686d48.

Kashdan, T. B., Jacob, R. G., Pelham, W. E., Lang, A. R., Hoza, B., Blumenthal, J. D., et al. (2004). Depression and anxiety in parents of children with ADHD and varying levels of oppositional defiant behaviors: Modeling relationships with family functioning. Journal of Clinical Child and Adolescent Psychology: The Official Journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53, 33(1), 169–181. https://doi.org/10.1207/S15374424JCCP3301_16.CrossRef

Kofler, M. J., Rapport, M. D., Bolden, J., Sarver, D. E., Raiker, J. S., & Alderson, R. M. (2011). Working memory deficits and social problems in children with ADHD. Journal of Abnormal Child Psychology, 39(6), 805–817. https://doi.org/10.1007/s10802-011-9492-8.CrossRefPubMed

Majewicz-Hefley, A., & Carlson, J. S. (2007). A meta-analysis of combined treatments for children diagnosed with ADHD. Journal of Attention Disorders, 10(3), 239–250. https://doi.org/10.1177/1087054706289934.CrossRefPubMed

MacDonald, B., Pennington, B. F., Willcutt, E. G., Dmitrieva, J., Samuelsson, S., Byrne, B., et al. (2019). Cross-country differences in parental reporting of symptoms of ADHD. Journal of Cross-Cultural Psychology, 50(6), 806–824. https://doi.org/10.1177/0022022119852422.CrossRefPubMedPubMedCentral

Margari, F., Craig, F., Petruzzelli, M. G., Lamanna, A., Matera, E., & Margari, L. (2013). Parents psychopathology of children with Attention Deficit Hyperactivity Disorder. Research in Developmental Disabilities, 34(3), 1036–1043. https://doi.org/10.1016/j.ridd.2012.12.001.CrossRefPubMed

Molina, B. S. G., Hinshaw, S. P., Swanson, J. M., Arnold, L. E., Vitiello, B., Jensen, P. S., … Houck, P. R. (2009). The MTA at 8 Years: Prospective Follow-up of Children Treated for Combined-Type ADHD in a Multisite Study. Journal of the American Academy of Child & Adolescent Psychiatry, 48(5), 484–500. https://doi.org/10.1097/CHI.0b013e31819c23d0.

Myrén, K.-J., Thernlund, G., Nylén, Å., Schacht, A., & Svanborg, P. (2010). Atomoxetine’s effect on societal costs in Sweden. Journal of Attention Disorders, 13(6), 618–628. https://doi.org/10.1177/1087054709332163.CrossRefPubMed

National Institute for Health and Clinical Excellence. (2018). Attention deficit hyperactivity disorder: diagnosis and management. NICE clinical guideline 87. https://www.nice.org.uk/guidance/ng87.

Newcorn, J. H., Kratochvil, C. J., Allen, A. J., Casat, C. D., Ruff, D. D., Moore, R. J., … Atomoxetine/Methylphenidate Comparative Study Group. (2008). Atomoxetine and osmotically released methylphenidate for the treatment of attention deficit hyperactivity disorder: Acute comparison and differential response. The American Journal of Psychiatry, 165(6), 721–730. https://doi.org/10.1176/appi.ajp.2007.05091676.

Ottosen, C., Petersen, L., Larsen, J. T., & Dalsgaard, S. (2016). Gender differences in associations between attention-deficit/hyperactivity disorder and substance use disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 55(3), 227–234.e4. https://doi.org/10.1016/j.jaac.2015.12.010.CrossRefPubMed

Parsons, T. D., Duffield, T., & Asbee, J. (2019). A comparison of virtual reality classroom continuous performance tests to traditional continuous performance tests in delineating ADHD: A meta-analysis. Neuropsychology Review, 29, 338–356. https://doi.org/10.1007/s11065-019-09407-6.

Polanczyk, G., de Lima, M. S., Horta, B. L., Biederman, J., & Rohde, L. A. (2007). The worldwide prevalence of ADHD: A systematic review and metaregression analysis. The American Journal of Psychiatry, 164(6), 942–948. https://doi.org/10.1176/ajp.2007.164.6.942.CrossRefPubMed

Raven, J. C., Court, J. H., & Raven, J. C. (1990). Manual for Raven’s progressive matrices and vocabulary scales—section 2: Coloured progressive matrices. Oxford: Oxford Psychologists Press.

Renoux, C., Shin, J.-Y., Dell’Aniello, S., Fergusson, E., & Suissa, S. (2016). Prescribing trends of attention-deficit hyperactivity disorder (ADHD) medications in UK primary care, 1995–2015. British Journal of Clinical Pharmacology, 82(3), 858–868. https://doi.org/10.1111/bcp.13000.CrossRefPubMedPubMedCentral

Rescorla, L., Achenbach, T. M., Ivanova, M. Y., Dumenci, L., Almqvist, F., Bilenberg, N., … Verhulst, F. (2007). Epidemiological comparisons of problems and positive qualities reported by adolescents in 24 countries. Journal of Consulting and Clinical Psychology, 75(2), 351–358. https://doi.org/10.1037/0022-006X.75.2.351.

Rescorla, L. A., Ginzburg, S., Achenbach, T. M., Ivanova, M. Y., Almqvist, F., Begovac, I., … Verhulst, F. C. (2013). Cross-Informant Agreement Between Parent-Reported and Adolescent Self-Reported Problems in 25 Societies. Journal of Clinical Child & Adolescent Psychology, 42(2), 262–273. https://doi.org/10.1080/15374416.2012.717870.

Sacchetti, G. M., & Lefler, E. K. (2014). ADHD symptomology and social functioning in college students. Journal of Attention Disorders. https://doi.org/10.1177/1087054714557355.CrossRefPubMed

Savill, N. C., Buitelaar, J. K., Anand, E., Day, K. A., Treuer, T., Upadhyaya, H. P., et al. (2015). The efficacy of atomoxetine for the treatment of children and adolescents with attention-deficit/hyperactivity disorder: A comprehensive review of over a decade of clinical research. CNS Drugs, 29(2), 131–151. https://doi.org/10.1007/s40263-014-0224-9.CrossRefPubMed

Schweren, L., Hoekstra, P., van Lieshout, M., Oosterlaan, J., Lambregts-Rommelse, N., Buitelaar, J., … Hartman, C. (2019). Long-term effects of stimulant treatment on ADHD symptoms, social-emotional functioning, and cognition. Psychological Medicine, 49(2), 217–223. https://doi.org/10.1017/S0033291718000545.

Smith, T., Aman, M. G., Arnold, L. E., Silverman, L. B., Lecavalier, L., Hollway, J., … Handen, B. L. (2016). Atomoxetine and parent training for children with autism and attention-deficit/hyperactivity disorder: A 24-week extension study. Journal of the American Academy of Child & Adolescent Psychiatry, 55(10), 868–876.e2. https://doi.org/10.1016/j.jaac.2016.06.015

Su, Y. (Esther), Wang, H., Geng, Y.-G., Sun, L., Du, Y.-S., Fan, F., & Su, L.-Y. (2015). Parent ratings of ADHD symptoms in Chinese urban schoolchildren: Assessment with the Chinese ADHD rating Scale–IV: Home version. Journal of Attention Disorders, 19(12), 1022–1033. https://doi.org/10.1177/1087054712461177.

Subcommittee on Attention-Deficit/Hyperactivity Disorder, Steering Committee on Quality Improvement and Management, Wolraich, M., Brown, L., Brown, R. T., DuPaul, G., … Visser, S. (2011). ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics, 128(5), 1007–1022. https://doi.org/10.1542/peds.2011-2654.

Svanborg, P., Thernlund, G., Gustafsson, P. A., Hägglöf, B., Schacht, A., & Kadesjö, B. (2009). Atomoxetine improves patient and family coping in attention deficit/hyperactivity disorder: A randomized, double-blind, placebo-controlled study in Swedish children and adolescents. European Child & Adolescent Psychiatry, 18(12), 725. https://doi.org/10.1007/s00787-009-0031-x.CrossRef

Szentagotai, A., Opriş, D., & David, D. (2011). Virtual reality in evidence-based psychotherapy. In J.-J. Kim (Ed.), Virtual reality (pp. 445–468). InTech. Retrieved from https://www.intechopen.com/books/virtual-reality/.

Taylor, E., Döpfner, M., Sergeant, J., Asherson, P., Banaschewski, T., Buitelaar, J., … Zuddas, A. (2004). European clinical guidelines for hyperkinetic disorder—first upgrade. European Child & Adolescent Psychiatry, 13(1), i7–i30. https://doi.org/10.1007/s00787-004-1002-x.

The MTA Cooperative Group. (1999). A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Archives of General Psychiatry, 56(12), 1073–1086. https://doi.org/10.1001/archpsyc.56.12.1073.CrossRef

Theule, J., Wiener, J., Tannock, R., & Jenkins, J. M. (2013). Parenting stress in families of children with ADHD: A meta-analysis. Journal of Emotional and Behavioral Disorders, 21(1), 3–17. https://doi.org/10.1177/1063426610387433.CrossRef

Thomas, R., Sanders, S., Doust, J., Beller, E., & Glasziou, P. (2015). Prevalence of attention-deficit/hyperactivity disorder: A systematic review and meta-analysis. Pediatrics, 135(4), e994–e1001. https://doi.org/10.1542/peds.2014-3482.CrossRefPubMed

Vernon, A. (2019). REBT with children and adolescents. In W. Dryden & M. E. Bernard (Eds.), REBT with diverse client problems and populations (pp. 243–263). Cham: Springer. https://doi.org/10.1007/978-3-030-02723-0_12.CrossRef

Vîslă, A., Flückiger, C., grosse Holtforth, M., & David, D. (2016). Irrational beliefs and psychological distress: A meta-analysis. Psychotherapy and Psychosomatics, 85(1), 8–15. https://doi.org/10.1159/000441231.

Waxmonsky, J. G., Waschbusch, D. A., Pelham, W. E., Draganac-Cardona, L., Rotella, B., & Ryan, L. (2010). Effects of atomoxetine with and without behavior therapy on the school and home functioning of children with attention-deficit/hyperactivity disorder. The Journal of Clinical Psychiatry, 71(11), 1535–1551. https://doi.org/10.4088/JCP.09m05496pur.CrossRefPubMed

Weisz, J. R., Kuppens, S., Ng, M. Y., Eckshtain, D., Ugueto, A. M., Vaughn-Coaxum, R., et al. (2017). What five decades of research tells us about the effects of youth psychological therapy: A multilevel meta-analysis and implications for science and practice. American Psychologist, 72(2), 79–117. https://doi.org/10.1037/a0040360.CrossRef

Wilens, T. E., & Biederman, J. (1992). The stimulants. Psychiatric Clinics, 15(1), 191–222. https://doi.org/10.1016/S0193-953X(18)30265-X.

Young, S., Moss, D., Sedgwick, O., Fridman, M., & Hodgkins, P. (2015). A meta-analysis of the prevalence of attention deficit hyperactivity disorder in incarcerated populations. Psychological Medicine, 45(2), 247–258. https://doi.org/10.1017/S0033291714000762.CrossRefPubMed

Zwi, M., Jones, H., Thorgaard, C., York, A., & Dennis, J. A. (2011). Parent training interventions for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 5 to 18 years. The Cochrane Database of Systematic Reviews, 2011(12). https://doi.org/10.1002/14651858.CD003018.pub3

Titel: Psychotherapy, Atomoxetine or Both? Preliminary Evidence from a Comparative Study of Three Types of Treatment for Attention-Deficit/Hyperactivity Disorder in Children
Auteurs: Daniel David
Anca Dobrean
Costina Ruxandra Păsărelu
Felicia Iftene
Viorel Lupu
Elena Predescu
Manfred Döpfner
Publicatiedatum: 02-10-2020
Uitgeverij: Springer US
Gepubliceerd in: Cognitive Therapy and Research / Uitgave 1/2021
Print ISSN: 0147-5916
Elektronisch ISSN: 1573-2819
DOI: https://doi.org/10.1007/s10608-020-10157-6

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Background

Methods

Results

Conclusions

Log in om toegang te krijgen

Andere artikelen Uitgave 1/2021

Emotion-Regulation in Psychosis: Patients with Psychotic Disorders Apply Reappraisal Successfully

Manipulating Alcohol Expectancies in Social Anxiety: A Focus on Beliefs About Losing Control

Development of the A-DISS Rejection Task to Demonstrate the Unique and Overlapping Affective Features of Social Anxiety and Depression

Advancing the Assessment of Mindfulness-Based Meditation Practice: Psychometric Evaluation of the Mindfulness Adherence Questionnaire

Developmental Differences in Child and Adolescent Reasoning About Anxiety Sensations

Brief Training to Modify the Breadth of Attention Influences the Generalisation of Fear